Patent Application
Utility
App. No. 14/290,691
· Confirmation No. 7378
NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS
Applicant:
Santarus, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2019-09-03 | ABN |
Abandonment | 2 | View | |
| 2019-02-25 | CTNF |
Non-Final Rejection | 16 | View | |
| 2019-02-25 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2019-02-25 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2019-02-05 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-02-05 | RCEX |
Request for Continued Examination (RCE) | 2 | View | |
| 2019-02-05 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-02-05 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-01-23 | CTAV |
Advisory Action (PTOL-303) | 3 | View | |
| 2019-01-23 | ANE.I |
Amendment After Final or under 37CFR 1.312, initialed by the examiner. | 1 | View | |
| 2018-12-27 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2018-12-27 | CLM |
Claims | 12 | View | |
| 2018-12-27 | REM |
Applicant Arguments/Remarks Made in an Amendment | 5 | View | |
| 2018-12-27 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-12-27 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2018-11-16 | CTFR |
Final Rejection | 16 | View | |
| 2018-11-16 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2018-11-16 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2018-11-16 | SRNT |
Examiner's search strategy and results | 7 | View | |
| 2018-10-29 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2018-10-29 | RCEX |
Request for Continued Examination (RCE) | 2 | View | |
| 2018-10-29 | XT/ |
Extension of Time | 2 | View | |
| 2018-10-29 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2018-10-29 | FOR |
Foreign Reference | 95 | View | |
| 2018-10-29 | FOR |
Foreign Reference | 137 | View | |
| 2018-10-29 | FOR |
Foreign Reference | 103 | View | |
| 2018-10-29 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2018-10-29 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2018-10-10 | INTV.SUM.APP |
Applicant Initiated Interview Summary (PTOL-413) | 3 | View | |
| 2018-06-27 | CTFR |
Final Rejection | 15 | View | |
| 2018-06-27 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2018-06-27 | SRNT |
Examiner's search strategy and results | 7 | View | |
| 2018-04-26 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2018-04-26 | CLM |
Claims | 11 | View | |
| 2018-04-26 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2018-04-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-04-26 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2018-01-26 | SRNT |
Examiner's search strategy and results | 7 | View | |
| 2018-01-26 | CTNF |
Non-Final Rejection | 15 | View | |
| 2018-01-26 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2017-10-18 | RCEX |
Request for Continued Examination (RCE) | 3 | View | |
| 2017-10-18 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2017-10-18 | CLM |
Claims | 11 | View | |
| 2017-10-18 | REM |
Applicant Arguments/Remarks Made in an Amendment | 3 | View | |
| 2017-10-18 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-10-18 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-10-18 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2017-07-26 | CTAV |
Advisory Action (PTOL-303) | 4 | View | |
| 2017-07-26 | ANE.I |
Amendment After Final or under 37CFR 1.312, initialed by the examiner. | 1 | View | |
| 2017-07-18 | A.NE |
Response After Final Action | 1 | View | |
| 2017-07-18 | CLM |
Claims | 11 | View | |
| 2017-07-18 | REM |
Applicant Arguments/Remarks Made in an Amendment | 3 | View | |
| 2017-07-18 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2017-07-18 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2017-04-18 | CTFR |
Final Rejection | 15 | View | |
| 2017-04-18 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2017-04-18 | SRNT |
Examiner's search strategy and results | 7 | View | |
| 2017-02-21 | RCEX |
Request for Continued Examination (RCE) | 2 | View | |
| 2017-02-21 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2017-02-21 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2017-02-21 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-02-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2017-02-21 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2017-01-20 | CTAV |
Advisory Action (PTOL-303) | 4 | View | |
| 2017-01-20 | ANE.I |
Amendment After Final or under 37CFR 1.312, initialed by the examiner. | 1 | View | |
| 2016-12-19 | A.NE |
Response After Final Action | 1 | View | |
| 2016-12-19 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2016-12-19 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-12-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2016-08-19 | CTFR |
Final Rejection | 14 | View | |
| 2016-08-19 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-08-19 | SRNT |
Examiner's search strategy and results | 6 | View | |
| 2016-08-02 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2016-08-02 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2016-08-02 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-08-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2016-02-02 | CTNF |
Non-Final Rejection | 11 | View | |
| 2016-02-02 | 892 |
List of references cited by examiner | 1 | View | |
| 2016-02-02 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2016-02-02 | SRNT |
Examiner's search strategy and results | 6 | View | |
| 2016-02-02 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2016-02-02 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-01-22 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2016-01-22 | CLM |
Claims | 11 | View | |
| 2016-01-22 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2016-01-22 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-01-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2016-01-22 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-11-20 | CTRS |
Requirement for Restriction/Election | 10 | View | |
| 2015-11-20 | 892 |
List of references cited by examiner | 1 | View | |
| 2014-09-18 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2014-06-09 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2014-06-09 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2014-06-09 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2014-05-29 | ADS |
Application Data Sheet | 8 | View | |
| 2014-05-29 | SPEC |
Specification | 92 | View | |
| 2014-05-29 | CLM |
Claims | 5 | View | |
| 2014-05-29 | ABST |
Abstract | 1 | View | |
| 2014-05-29 | DRW |
Drawings-only black and white line drawings | 17 | View | |
| 2014-05-29 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2014-05-29 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2014-05-29 | WFEE |
Fee Worksheet (SB06) | 1 | View |
Inventors
Warren Hall
San Diego, CA
Laura Weston
Escondido, CA
Kay Olmstead
San Diego, CA
Laura Gallo
Oceanside, CA
Craig Bowe
San Diego, CA
Attorneys & Agents of Record
Classification
USPC
424/76.1
A61K31/4439
A61K9/0056
A61K9/14
A61K9/145
A61K9/1641
A61K9/1652
A61K9/2009
A61K9/2013
A61K9/2018
A61K9/2054
A61K9/2059
A61K9/209
A61K9/2866
A61K9/4808
A61K9/4858
A61K9/4866
A61K9/5042
A61K9/5047
A61K9/5084
A61K31/44
A61K33/00
A61K33/08
A61K33/10
A61K33/14
A61K2300/00
Prosecution
- Examiner
- KASSA, TIGABU
- Art Unit
- 1619
- Customer No.
- 120260
- Docket No.
- 20215.0039.CNUS00
- Confirmation No.
- 7378
Publication
- Pub. No.
- US20140271853A1
- Pub. Date
- 2014-09-18
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH US, LLC,
SOLTA MEDICAL, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2019-03-11
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
GLYCYX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.
SECURITY AGREEMENT
Recorded 2015-04-02
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 14/290,691
- Filed
- 2014-05-29
- Pub. No.
- US20140271853A1
- Examiner
- KASSA, TIGABU
- Art Unit
- 1619
External Links